A drug designed to combat Tuberous Sclerosis is being trialled at Cardiff University and could also be used to treat autism. Everolimus has already proven effective when used to treat kidney growths and grain tumours - reducing their size in many cases.
Tuberous Sclerosis is a genetic disorder characterised by the development of tumours in many organs, including the skin and kidneys. It can also affect the brain, leading to epilepsy and often ADHD and autism.
For more health stories click here.
More top news
A warm and muggy night with showers, occasionally thundery in the south. These will gradually clear eastwards through the early hours
The world record for the largest scrum was broken in Cardiff today after 1,297 rugby players from across the globe took part.
Chris Coleman: Wales position 'something very special and close to my heart'.